Abbott says access to prostate cancer drug widened

NEW YORK (Reuters) - Abbott Laboratories said on Thursday it has received U.S. regulatory approval to make its experimental prostate cancer drug Xinlay available to certain patients even though it is not yet approved.

Continue to Abbott says access to prostate cancer drug widened on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz